| Dr David Joseph Young, DO | |
|
595 W State St, Doylestown, PA 18901-2554 | |
| (215) 345-0105 | |
| (215) 345-0562 |
| Full Name | Dr David Joseph Young |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 39 Years |
| Location | 595 W State St, Doylestown, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194817627 | NPI | - | NPPES |
| 1194817627 | Other | PA | GHP |
| 0011621840007 | Medicaid | PA | |
| 25-1645055 | Other | PA | CIGNA-GREAT WEST HEALTHCARE |
| 25-1645055 | Other | PA | COVENTRY/HEALTH AMERICA |
| P011117493 | Other | PA | RR MEDICARE |
| 0011621840006 | Medicaid | PA | |
| 50110611 | Other | PA | CAPITAL BLUE CROSS |
| 829910 | Other | PA | FPH |
| 4113114 | Other | PA | AETNA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | OS005905L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Doylestown Hospital | Doylestown, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Via Affiliates | 1759295512 | 182 |
News Archive
Unigene Laboratories, Inc. (http://www.unigene.com) today announced that it has entered into an amended and restated financing agreement for $33 million three-year convertible senior secured term notes.
Isis Pharmaceuticals, Inc. announced today positive results from a Phase 1 study with ISIS-FXIRx. The results demonstrated that treatment with ISIS-FXIRx produced dose-dependent statistically significant reductions of up to 78 percent in Factor XI activity.
ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, announces that further data from the first successful Phase III trial with microplasmin (TG-MV-006) for the non-surgical treatment of vitreomacular adhesion (VMA) were presented at the World Ophthalmology Congress by Dr. Matthew Benz, MD (The Methodist Hospital, Houston, Texas, U.S.)
According to new study in the U.S. children who are exposed to cats soon after birth may have an increased risk of developing eczema, while being exposed to two or more dogs at home may offer some slight protection.
Researchers have lab-tested a molecule that can combat the common cold virus by preventing it from hijacking human cells.
› Verified 4 days ago
| Entity Name | Via Affiliates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003446261 PECOS PAC ID: 1759295512 Enrollment ID: O20031117000104 |
News Archive
Unigene Laboratories, Inc. (http://www.unigene.com) today announced that it has entered into an amended and restated financing agreement for $33 million three-year convertible senior secured term notes.
Isis Pharmaceuticals, Inc. announced today positive results from a Phase 1 study with ISIS-FXIRx. The results demonstrated that treatment with ISIS-FXIRx produced dose-dependent statistically significant reductions of up to 78 percent in Factor XI activity.
ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, announces that further data from the first successful Phase III trial with microplasmin (TG-MV-006) for the non-surgical treatment of vitreomacular adhesion (VMA) were presented at the World Ophthalmology Congress by Dr. Matthew Benz, MD (The Methodist Hospital, Houston, Texas, U.S.)
According to new study in the U.S. children who are exposed to cats soon after birth may have an increased risk of developing eczema, while being exposed to two or more dogs at home may offer some slight protection.
Researchers have lab-tested a molecule that can combat the common cold virus by preventing it from hijacking human cells.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David Joseph Young, DO Po Box 829641, Philadelphia, PA 19182-0001 Ph: (267) 370-5295 | Dr David Joseph Young, DO 595 W State St, Doylestown, PA 18901-2554 Ph: (215) 345-0105 |
News Archive
Unigene Laboratories, Inc. (http://www.unigene.com) today announced that it has entered into an amended and restated financing agreement for $33 million three-year convertible senior secured term notes.
Isis Pharmaceuticals, Inc. announced today positive results from a Phase 1 study with ISIS-FXIRx. The results demonstrated that treatment with ISIS-FXIRx produced dose-dependent statistically significant reductions of up to 78 percent in Factor XI activity.
ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, announces that further data from the first successful Phase III trial with microplasmin (TG-MV-006) for the non-surgical treatment of vitreomacular adhesion (VMA) were presented at the World Ophthalmology Congress by Dr. Matthew Benz, MD (The Methodist Hospital, Houston, Texas, U.S.)
According to new study in the U.S. children who are exposed to cats soon after birth may have an increased risk of developing eczema, while being exposed to two or more dogs at home may offer some slight protection.
Researchers have lab-tested a molecule that can combat the common cold virus by preventing it from hijacking human cells.
› Verified 4 days ago
Dr. Aaron David Boerner, DPT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 101 Progress Dr, Doylestown, PA 18901 Phone: 215-489-8550 | |
Dr. Sean Patrick Butler, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 800 W State St, Suite 202, Doylestown, PA 18901 Phone: 215-348-3068 Fax: 215-348-7428 | |
David James Van Why, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 595 W State St, Doylestown, PA 18901 Phone: 215-663-6608 Fax: 215-345-2511 |